A Prospective Comparison of Ceftriaxone and Levofloxacin for Surgical Site Infection Prophylaxis in Elective General Surgeries

Background: Surgical Site Infections (SSIs) are prevalent postoperative complications that can lead to increased morbidity, prolonged hospital stays, and elevated healthcare costs. Prophylactic antibiotic administration is a standard practice aimed at reducing the incidence of SSIs. This study compares the efficacy of ceftriaxone and levofloxacin as prophylactic antibiotics in patients undergoing elective general surgeries. Methods: A prospective, comparative study was conducted involving 100 patients scheduled for elective general surgeries. Participants were randomized into two groups: Group A received a single preoperative dose of ceftriaxone (1g IV), and Group B received levofloxacin (750mg IV). Data collected included patient demographics, type of surgery, incidence and grading of SSIs (using the Southampton grading system), microbiological profiles of infections, duration of hospital stay, and total antibiotic dosage administered. Results: The overall incidence of SSIs was 39%, with 22 cases in the ceftriaxone group and 17 in the levofloxacin group (p = 0.78). The most common procedures associated with SSIs were hernioplasty and cholecystectomy. Predominant pathogens isolated included Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Patients in the levofloxacin group had a shorter mean hospital stay, with 48% discharged within three days, compared to 8% in the ceftriaxone group. Additionally, 76% of patients in the levofloxacin group required ≤4 mg of antibiotics, whereas 78% in the ceftriaxone group required 4–10 mg. Conclusion: Both ceftriaxone and levofloxacin are effective as prophylactic antibiotics in elective general surgeries. However, levofloxacin demonstrated advantages in terms of shorter hospital stays and lower total antibiotic consumption. These findings suggest that levofloxacin may be a more cost-effective option for SSI prophylaxis in elective general surgical procedures.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-15
DOI
https://doi.org/10.5281/zenodo.15422867
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Prospective Comparison of Ceftriaxone and Levofloxacin for Surgical Site Infection Prophylaxis in Elective General Surgeries

Zenodo (CERN European Organization for Nuclear Research)
Vitamin D Research Studies
article

A Prospective Comparison of Ceftriaxone and Levofloxacin for Surgical Site Infection Prophylaxis in Elective General Surgeries

article en

Abstract

Background: Surgical Site Infections (SSIs) are prevalent postoperative complications that can lead to increased morbidity, prolonged hospital stays, and elevated healthcare costs. Prophylactic antibiotic administration is a standard practice aimed at reducing the incidence of SSIs. This study compares the efficacy of ceftriaxone and levofloxacin as prophylactic antibiotics in patients undergoing elective general surgeries. Methods: A prospective, comparative study was conducted involving 100 patients scheduled for elective general surgeries. Participants were randomized into two groups: Group A received a single preoperative dose of ceftriaxone (1g IV), and Group B received levofloxacin (750mg IV). Data collected included patient demographics, type of surgery, incidence and grading of SSIs (using the Southampton grading system), microbiological profiles of infections, duration of hospital stay, and total antibiotic dosage administered. Results: The overall incidence of SSIs was 39%, with 22 cases in the ceftriaxone group and 17 in the levofloxacin group (p = 0.78). The most common procedures associated with SSIs were hernioplasty and cholecystectomy. Predominant pathogens isolated included Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Patients in the levofloxacin group had a shorter mean hospital stay, with 48% discharged within three days, compared to 8% in the ceftriaxone group. Additionally, 76% of patients in the levofloxacin group required ≤4 mg of antibiotics, whereas 78% in the ceftriaxone group required 4–10 mg. Conclusion: Both ceftriaxone and levofloxacin are effective as prophylactic antibiotics in elective general surgeries. However, levofloxacin demonstrated advantages in terms of shorter hospital stays and lower total antibiotic consumption. These findings suggest that levofloxacin may be a more cost-effective option for SSI prophylaxis in elective general surgical procedures.

Zenodo (CERN European Organization for Nuclear Research)
Noble Hospital (IN)
Good health and well-being
Openalex Percentile: Top 41%
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Prospective Comparison of Ceftriaxone and Levofloxacin for Surgical Site Infection Prophylaxis in Elective General Surgeries · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS